Multimodal Imaging Analysis of Retinal and Microvascular Changes in Alport Syndrome
-
By
-
Irem Kirci Dogan
-
Caner Incekas
-
Imren Akkoyun
-
Sezin Akca Bayar
-
Gursel Yilmaz
-
January 19, 2026
-
Clinical Scorecard: Multimodal Imaging Analysis of Retinal and Microvascular Changes in Alport Syndrome
At a Glance
| Category | Detail |
|---|
| Condition | Alport Syndrome |
| Key Mechanisms | Pathogenic variants in COL4A3, COL4A4, or COL4A5 genes affecting type IV collagen structure. |
| Target Population | Patients with genetically or clinically confirmed Alport syndrome. |
| Care Setting | Tertiary referral center. |
Key Highlights
- Prevalence estimated at 1 in 2,320 for X-linked and 1 in 106 for autosomal dominant forms.
- Ocular manifestations include anterior lenticonus and dot-and-fleck retinal changes.
- Microvascular alterations observed via OCT-A, including reduced FAZ area and vascular density.
- Study involved 34 patients with AS and 68 matched controls.
- Comprehensive evaluation using spectral-domain OCT and swept-source OCT-A.
Guideline-Based Recommendations
Diagnosis
- Genetic confirmation via pathogenic variants in COL4A3, COL4A4, or COL4A5.
- Clinical diagnosis based on systemic and ocular features.
Management
- Regular ophthalmologic examinations including BCVA and fundus examination.
Monitoring & Follow-up
- Utilization of OCT and OCT-A for assessing retinal structure and microvascular changes.
Risks
- Exclusion of patients with other retinal diseases or significant media opacity.
Patient & Prescribing Data
Patients with genetically or clinically confirmed Alport syndrome.
Focus on monitoring ocular manifestations and structural changes.
Clinical Best Practices
- Conduct comprehensive ophthalmologic examinations.
- Utilize OCT for detailed retinal layer analysis.
- Ensure accurate genetic testing for diagnosis.
References
